Literature DB >> 8504039

Increased interleukin 6, but reduced interleukin 1, in delayed pressure urticaria.

F Lawlor1, C Bird, R D Camp, R Barlow, R M Barr, A Kobza-Black, M R Judge, M W Greaves.   

Abstract

Interleukin 1 (IL-1) and interleukin 6 (IL-6) were measured by bioassays in suction-blister exudates from lesional skin, from skin immediately following a pressure challenge, and from control skin (not subjected to pressure) of patients with delayed pressure urticaria. IL-6 activity in lesional exudates was significantly higher than in exudates from the other two sites. IL-1 activity in lesional exudates was not significantly higher than in the control exudates, but significantly less IL-1 activity was found immediately after pressure challenge than from the control site.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504039     DOI: 10.1111/j.1365-2133.1993.tb00225.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

Review 1.  Histopathology of chronic urticaria.

Authors:  G Edward Stewart
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

2.  Evidence for histamine release in chronic inducible urticaria - A systematic review.

Authors:  Kanokvalai Kulthanan; Martin K Church; Eva Maria Grekowitz; Tomasz Hawro; Lea Alice Kiefer; Kanyalak Munprom; Yanisorn Nanchaipruek; Chuda Rujitharanawong; Dorothea Terhorst-Molawi; Marcus Maurer
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

3.  Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU812 cells.

Authors:  Zafar Rasheed; Nahid Akhtar; Arivarasu N Anbazhagan; Sangeetha Ramamurthy; Meenakshi Shukla; Tariq M Haqqi
Journal:  J Inflamm (Lond)       Date:  2009-01-08       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.